CorMedix Inc. (CRMD) stock
CRMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/30
$4.67−0.15 (-3.11%)
Close on Nov 17, 2026Market cap $364.00MP/E –Yield –
CorMedix EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
CorMedix's EV/EBITDA was 0.7× on Nov 11, 2026, against 6.9× a year earlier.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.7× | −7.5 |
| 2025 | Dec 31, 2025 | 8.2× | – |
See a number that looks wrong?